Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions.

In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases.

Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. 

Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. 

Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. 

Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.

Biotechnology

Life Sciences

Pharmaceutical

Kedrion Biopharma

Ugo Di Francesco

Steve Higgins

Dan Delgado

Federico Latini

Gorana Dasic M.D.

Andrea Caricasole

Bob Rossilli

Gionni Bernardini

Joana Silvério Marques

Paloma de Miguel

Akos Toth

Tommaso Paoli

Massimiliano Barberis

Sales and Marketing

Leadership Team

Engineering and Technology

Quality Assurance and Compliance

Finance and Accounting

Human Resources and Talent Management

Medical Affairs and Clinical Research

Teams at Kedrion Biopharma